These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21559523)

  • 1. TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma.
    Lin K; Taylor JR; Wu TD; Gutierrez J; Elliott JM; Vernes JM; Koeppen H; Phillips HS; de Sauvage FJ; Meng YG
    PLoS One; 2011 Apr; 6(4):e18608. PubMed ID: 21559523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer.
    Lee SM; Park JY; Kim DS
    Mol Cells; 2012 Aug; 34(2):171-6. PubMed ID: 22814847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas.
    Xie S; Zhang Y; Peng T; Guo J; Cao Y; Guo J; Shi X; Li Y; Liu Y; Qi S; Wang H
    Cancer Cell Int; 2021 Mar; 21(1):148. PubMed ID: 33663520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17.
    Ali N; Knaüper V
    J Biol Chem; 2007 Dec; 282(52):37378-88. PubMed ID: 17942404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis.
    Silber J; Jacobsen A; Ozawa T; Harinath G; Pedraza A; Sander C; Holland EC; Huse JT
    PLoS One; 2012; 7(3):e33844. PubMed ID: 22479456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-323-3p Targeting Transmembrane Protein with EGF-Like and 2 Follistatin Domain (TMEFF2) Inhibits Human Lung Cancer A549 Cell Apoptosis by Regulation of AKT and ERK Signaling Pathways.
    Fan JM; Zheng ZR; Zeng YM; Chen XY
    Med Sci Monit; 2020 Feb; 26():e919454. PubMed ID: 32009129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer.
    Afar DE; Bhaskar V; Ibsen E; Breinberg D; Henshall SM; Kench JG; Drobnjak M; Powers R; Wong M; Evangelista F; O'Hara C; Powers D; DuBridge RB; Caras I; Winter R; Anderson T; Solvason N; Stricker PD; Cordon-Cardo C; Scher HI; Grygiel JJ; Sutherland RL; Murray R; Ramakrishnan V; Law DA
    Mol Cancer Ther; 2004 Aug; 3(8):921-32. PubMed ID: 15299075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEFF2 is an endogenous inhibitor of the CRH signal transduction pathway.
    Labeur M; Wölfel B; Stalla J; Stalla GK
    J Mol Endocrinol; 2015 Feb; 54(1):51-63. PubMed ID: 25573902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of TMEFF2 in Human Pancreatic Cancer Tissue and the Effects of TMEFF2 Knockdown on Cell, Proliferation, and Apoptosis in Human Pancreatic Cell Lines.
    Li K; Gu W; Xu J; Wang A; Han H
    Med Sci Monit; 2019 May; 25():3238-3246. PubMed ID: 31044775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor suppressor activity of the transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) correlates with its ability to modulate sarcosine levels.
    Chen X; Overcash R; Green T; Hoffman D; Asch AS; Ruiz-Echevarría MJ
    J Biol Chem; 2011 May; 286(18):16091-100. PubMed ID: 21393249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional regulation between TMEFF2 and STAT3 may contribute to Helicobacter pylori-associated gastric carcinogenesis.
    Sun TT; Tang JY; Du W; Zhao HJ; Zhao G; Yang SL; Chen HY; Hong J; Fang JY
    Int J Cancer; 2015 Mar; 136(5):1053-64. PubMed ID: 24996057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer.
    Gaweł-Bęben K; Ali N; Ellis V; Velasco G; Poghosyan Z; Ager A; Knäuper V
    Cell Biol Int; 2018 Mar; 42(3):273-280. PubMed ID: 28762604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMEFF2 deregulation contributes to gastric carcinogenesis and indicates poor survival outcome.
    Sun T; Du W; Xiong H; Yu Y; Weng Y; Ren L; Zhao H; Wang Y; Chen Y; Xu J; Xiang Y; Qin W; Cao W; Zou W; Chen H; Hong J; Fang JY
    Clin Cancer Res; 2014 Sep; 20(17):4689-704. PubMed ID: 24987055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
    Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R
    J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
    Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
    Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMEFF2: A Transmembrane Proteoglycan with Multifaceted Actions in Cancer and Disease.
    Masood M; Grimm S; El-Bahrawy M; Yagüe E
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33371267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
    Bruna A; Darken RS; Rojo F; Ocaña A; Peñuelas S; Arias A; Paris R; Tortosa A; Mora J; Baselga J; Seoane J
    Cancer Cell; 2007 Feb; 11(2):147-60. PubMed ID: 17292826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
    Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
    Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMEFF2 modulates the AKT and ERK signaling pathways.
    Chen X; Ruiz-Echevarría MJ
    Int J Biochem Mol Biol; 2013; 4(2):83-94. PubMed ID: 23936739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor and platelet-derived growth factor induce expression of Egr-1, a zinc finger transcription factor, in human malignant glioma cells.
    Kaufmann K; Thiel G
    J Neurol Sci; 2001 Aug; 189(1-2):83-91. PubMed ID: 11535237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.